Quote | Super Quote
Super Quote   |   Detail Quote   |   Interactive Chart   |   Transaction   |   Related News   |   Related Securities   |   Company Information   |   Dividend Records   |   Short Sell
02196 FOSUN PHARMA
RT Nominal up13.900 +0.060 (+0.434%)
Latest  |  Final  |  Interim
Non-current Assets
2023/12 - Final
RMB(K¥)
%Chg
(Compare to Final)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
2019/12
RMB(K¥)
Investment Properties0--0000
Property, plant, equip. & others20,846,45832.621%15,718,78913,012,07512,579,87310,720,960
Land & other Lease Assets4,248,08049.726%2,837,2292,569,7962,666,4022,454,742
Intangible Assets26,153,7877.679%24,288,67821,010,69918,254,99018,050,236
Interests in Asso. & JCEs23,881,0233.408%23,094,05522,626,82722,252,58220,872,889
Other Non-current Assets4,509,310-23.510%5,895,2623,593,1312,790,4733,560,564

79,638,65810.865%71,834,01362,812,52858,544,32055,659,391
Current Assets
2023/12 - Final
RMB(K¥)
%Chg
(Compare to Final)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
2019/12
RMB(K¥)
Inventories7,537,7689.522%6,882,4325,472,5475,162,8003,940,537
Trade Receivables7,668,2290.726%7,612,9426,045,9474,807,0594,607,722
Cash & Bank Balances13,693,591-15.687%16,241,31310,317,2249,961,8029,533,268
Other Current Assets4,892,98118.678%4,122,9128,137,4835,153,1422,321,841
Assets Held for Sale0--419,578463,70500

33,792,569-4.214%35,279,17730,436,90625,084,80320,403,368
Current Liabilities
2023/12 - Final
RMB(K¥)
%Chg
(Compare to Final)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
2019/12
RMB(K¥)
Trade Payables6,159,619-1.980%6,284,0415,063,6933,289,0212,397,315
S-T Debt & Leases19,433,26712.886%17,214,87715,626,08115,033,1098,703,988
Other Current Liabilities8,164,695-16.680%9,799,1528,628,6996,550,2236,332,463
Liab asso w/ Assets Held for Sale0--0000

33,757,5811.380%33,298,07029,318,47324,872,35317,433,766
Net Current Assets34,988-98.234%1,981,1071,118,433212,4502,969,602
Total Assets Less Current Liabilities79,673,6467.937%73,815,12063,930,96158,756,77058,628,993
Non-current Liabilities
2023/12 - Final
RMB(K¥)
%Chg
(Compare to Final)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
2019/12
RMB(K¥)
L-T Debt & Leases15,554,51221.095%12,844,8609,697,4299,102,97612,987,095
Other Non-current Liabilities7,541,2499.103%6,912,0675,910,8503,726,3986,494,572

23,095,76116.900%19,756,92715,608,27912,829,37419,481,667
Capital and Reserves
2023/12 - Final
RMB(K¥)
%Chg
(Compare to Final)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
2019/12
RMB(K¥)
  Share Capital2,672,3990.009%2,672,1572,562,8992,562,8992,562,899
  Reserves42,973,9872.662%41,859,58436,575,77334,375,74829,268,280
  Others0--0000
Shareholders' Funds45,646,3862.503%44,531,74139,138,67236,938,64731,831,179
Non-controlling Interests10,931,49914.749%9,526,4529,184,0108,988,7497,316,147
Others0--0000

56,577,8854.661%54,058,19348,322,68245,927,39639,147,326
Commitments and Contingent Liabilities
2023/12 - Final
RMB(K¥)
%Chg
(Compare to Final)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
2019/12
RMB(K¥)
Commitments4,282,798-33.804%6,469,8437,774,3827,826,1057,680,268
Contingent Liabilities0--0000
Remarks:  Real time quote last updated: 23/12/2024 11:22
  Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service
Security Code
Company Name (Chi/Eng/Keywords)
Industry
Profit / (Loss) Attributable to Shareholders (K¥)RMB 1,224,799
%Change-31.332%
EPS / (LPS)RMB 0.460
NBV Per Share (¥)RMB 17.561
A Member of HKET Holdings
Customer Service Hotline:(852) 2880 7004     Customer Service Email:cs@etnet.com.hk
Copyright 2024 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.